Literature DB >> 24670179

Abatacept in B7-1-positive proteinuric kidney disease.

Ariela Benigni, Elena Gagliardini, Giuseppe Remuzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24670179     DOI： 10.1056/NEJMc1400502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  30 in total

1.  Therapy: New data do not support use of abatacept in diabetic nephropathy.

Authors:  Gerald B Appel
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

2.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 3.  Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pediatr Nephrol       Date:  2015-05-05       Impact factor: 3.714

Review 4.  Podocytes from the diagnostic and therapeutic point of view.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pflugers Arch       Date:  2017-05-16       Impact factor: 3.657

Review 5.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

Review 6.  Focal segmental glomerular sclerosis: do not overlook the role of immune response.

Authors:  Francesco Reggiani; Claudio Ponticelli
Journal:  J Nephrol       Date:  2016-02-20       Impact factor: 3.902

7.  Costimulatory blockade: A novel approach to the treatment of glomerular disease?

Authors:  Pasquale Esposito; Teresa Rampino; Antonio Dal Canton
Journal:  World J Methodol       Date:  2015-06-26

8.  Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.

Authors:  Eduardo H Garin; Jochen Reiser; Gabriel Cara-Fuentes; Changli Wei; Dany Matar; Heiman Wang; Nada Alachkar; Richard J Johnson
Journal:  Pediatr Nephrol       Date:  2014-09-20       Impact factor: 3.714

Review 9.  The next generation of therapeutics for chronic kidney disease.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Nat Rev Drug Discov       Date:  2016-05-27       Impact factor: 84.694

Review 10.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.